European Journal of Hospital Pharmacy

Papers
(The median citation count of European Journal of Hospital Pharmacy is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?45
Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients39
Medication reconciliationis it possible to speed up without compromising quality? A before–after study in the emergency department36
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?35
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document19
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews13
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series12
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing11
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide10
Spain takes over Presidency of the Council of the European Union10
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study10
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings10
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-1910
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years9
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20229
Factors influencing accuracy when preparing injectable drug concentrations in appliance with clinical practice: a norepinephrine case study9
Infectious diseases and antimicrobial resistance9
Medicines Delivery Proximity Programme (PEMProxi) survey results9
SARS-CoV-2: an opportunity for hospital pharmacy9
Medicine shortages in France: a 6-year retrospective study in a university medical centre8
EAHP’s new President András Süle starts his term together with eight newly elected Board members8
EAHP’s needs assessment survey8
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation7
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases7
Analysis of adverse drug events as a way to improve cancer patient care7
COP27 climate change conference: urgent action needed for Africa and the world6
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations6
Antifungal drug resistance: an update6
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-196
The CLEO assessment tool for pharmacist interventions6
Medical device resources for hospital pharmacists6
Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project5
EAHP sets out to future-proof the hospital pharmacy workforce5
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave5
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review5
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence5
Capecitabine: guaranteed access in adjuvant treatment of breast cancer5
Biological therapy for ocular Behçet’s disease with off-label drug prescription in Turkey5
Potential impact of national recommendations to use short course antibiotic therapy on antibiotic use in the emergency department of a UK hospital: retrospective observational study4
Performance and risks of ChatGPT used in drug information: comment4
The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-194
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness4
Automation of parenteral nutrition: impact on process and cost analysis4
Factors affecting voriconazole concentration to dose ratio changes according to route of administration4
Epileptic convulsions probably induced by desloratadine: a case report4
Potential therapeutic effects of different mouthwashes for alleviation and treatment of oral complications of 5-fluorouracil-based chemotherapy in patients with colon cancer4
Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation4
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients4
Advanced therapy medicinal products4
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy4
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags4
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review4
Optimised quality control method for determination of the radiochemical purity of [99mTc]Tc-mebrofenin and [99mTc]Tc-etifenin in a clinical context4
Testing of parenteral drug products for visible particles: comparison of the Ph. Eur. method with an alternative method using polarised light3
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?3
Successful desensitisation to paclitaxel with omalizumab3
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital3
Optimising adalimumab administration to improve patient experience and treatment adherence in immune-mediated inflammatory diseases3
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK3
Clinical pharmacy interventions in an Austrian hospital: a report highlights the need for the implementation of clinical pharmacy services3
Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors3
Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections3
Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards3
Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots3
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease3
Investigation of the hospital pharmacy profession in Europe3
Investigating the capabilities of advanced large language models in generating patient instructions and patient educational material3
Increasing the number of pharmacist-led medication order reviews using the available workforce: a retrospective study3
Investigation on the knowledge level of the rational application of antimicrobial drugs among pharmacists in medical institutions in Shanxi Province3
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines3
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators3
Performance evaluation of the HPLC diode array and evaporative light scattering detection for the implementation of dose-banded gemcitabine infusion bags3
Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study3
Medication-related problems in critical care survivors: a systematic review3
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients3
Stability assessment and content determination test of oral liquid forms of beclomethasone dipropionate prepared in hospital pharmacy3
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain3
Inpatient case characteristics of SGLT2 inhibitor-associated diabetic ketoacidosis: a retrospective study2
Design and validation of a predictive equation to estimate unbound valproic acid concentration2
Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique2
Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use2
Optimisation of the quality of care for patients with severe asthma: ASfarMA project2
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report2
Qualification and impact of a video-assisted control system in a chemotherapy compounding unit2
Drugs associated with tachyphylaxis: results from a retrospective pharmacovigilance study using disproportionality analysis2
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey2
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-192
Results of EAHP’s 2023 shortages survey2
Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy2
Prevalence of potentially inappropriate prescriptions identified using screening tools in paediatric patients: a systematic review2
Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome2
Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting2
Frequency of paediatric patients administered extemporaneous preparations at a Swedish university hospital: a registry-based study comparing two study-years, 10 years apart2
Toward a better understanding about real-world evidence2
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?2
Effectiveness of a low trough serum concentration of vancomycin on acute kidney injury in infants and toddlers in the paediatric intensive care unit2
Optimising electronic health records for highly specialised hospital areas: a call for collaborative hospital pharmacist involvement2
Real-world evidence: what is it and can it be trusted?2
Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients2
Implementation and effectiveness of pharmacist-led interviews at patient hospital admission in a rheumatology department2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients2
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study2
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology2
Introduction to an online only issue2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Clinical experience with immunotherapy in patients with diffuse intrinsic pontine glioma2
Stability of intravenous medicines – evidence of maximum temperature reached in both summer and winter within soft shell elastomeric pumps2
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric population2
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions2
Potential risk of non-arteritic anterior ischaemic optic neuropathy in semaglutide users: pharmacovigilance insights2
The environmental impact of inhalers: a framework for sustainable prescription practices in Spain2
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam2
Clinical pharmacists’ services, role and acceptance: a national Swedish survey2
The threatened medicines information pharmacist!2
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors2
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze2
EJHP’s impact factor moves on up2
Can antibiotics affect the clinical features of patients with candidemia? The retrospective evaluation of 5 years of data in an intensive care unit2
Development and prioritisation of policy recommendations for medication safety improvement for intensive care units: a European Association of Hospital Pharmacists Special Interest Group Delphi Study2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials2
Liquid antimicrobials: a national analysis of critical shortages2
Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physicians2
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study2
Hazardous medicinal products2
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients2
Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases2
Failure mode and effect analysis applied to improve the medication management process in a pharmacy of a teaching hospital and a proposal for a simplified rating system2
Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey2
Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study2
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection1
Information on COVID-19 vaccines and vaccinations1
Benefit versus toxicity risk of digoxin in patients with COVID-191
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations1
Antimicrobial resistance: a major priority for global focus1
An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage1
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature1
Comparison of three automated compounding devices for parenteral nutrition according to four key technical tests1
Keeping the focus on antimicrobials1
Public information on shortages in the EU/EEA: improvements made between 2018 and 20201
Antimicrobial resistance in Nigeria: challenges and charting the way forward1
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report1
Correction: Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?1
COVID-19 vaccine triggered autoimmune hepatitis: case report1
Older people, medication usage and long-term care pharmacists: a retrospective cohort study1
Evaluation of resources for effective decision-making about drug manipulation1
Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial1
Looking back and looking forward1
Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data1
EAHP general assembly updates position paper on clinical trials1
Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags1
Empowering European hospital pharmacists in the face of heart failure1
Digital medication management in healthcare settings1
Roberto Frontini appointed as a member of PRAC1
Unexpected overdose of oral cyclosporine in a kidney transplant patient: a case report1
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series1
Rational use of metaraminol can improve pharmaceutical care1
European health data space proposal launched1
Extemporaneous preparation of rifampicin granules from capsules to improve usability1
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines1
Analysis of medication-related triggers to determine adverse drug events1
SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces1
EAHP opinion on COVID-19 vaccine programmes and their implementation1
The potential for deprescribing in a palliative oncology patient population: a cross-sectional study1
Adverse reactions to antimicrobials in pediatric patients admitted to a tertiary hospital: a cohort study1
Hospital pharmacy specialisation1
Defining a new term: defensive hospital pharmacy practices1
Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis1
Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation1
Choice of pharmaceutical form as a key factor during ketogenic diet: a case report1
Using risk analysis to ensure patients’ medication safety during hospital relocations and evacuations1
Clinical benefits of therapeutic drug monitoring of vancomycin therapy in patients with postoperative intracerebral hemorrhage: a retrospective cohort study1
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome1
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions1
Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens1
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report1
Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case–control study1
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis1
Analysis of the clinical characteristics of dabigatran-induced oesophagitis1
Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer1
EAHP-EANM joint statement1
The importance of publishing research protocols for pharmacoeconomic studies1
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study1
Pilot study of a European oncology regimen reference library and matching algorithm1
Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation1
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy1
EMA guidance for industry to prevent and mitigate medicine shortages1
Influence of volume and citrate on perceived pain in patients treated with adalimumab1
Does the use of new cephalosporins follow the authorised, financed and approved indications? A study of their use in routine clinical practice in a tertiary hospital1
The end of an era!1
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?1
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?1
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs1
Spice-drug interactions: a case report on the use of turmeric, curry and ginger in a renal transplant patient on tacrolimus1
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients1
Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistantAcinetobacter baumanniistrains: a time series analysis1
Call for emergency action to limit global temperature increases, restore biodiversity and protect health1
Fixed drug eruption after pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus andHaemophilus influenzaetype b combined vaccine in an infant1
The geriatric clinical pharmacist at the emergency department: a novel front-door transdisciplinary care model1
Accuracy of an electronic prescribing system for standard treatments1
A new approach to drug intravenous compatibility research: the case of obstetric parenteral drugs1
Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem1
Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France1
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods1
Transition to adult services: the current and potential role of the UK hospital pharmacist1
Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centre1
Comparison of adverse drug reactions of statins in China from 1989 to 20191
Implementation of pharmacists’ monitoring for intravenous drug compatibility1
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice1
Recommended doses of endovenous vancomycin are insufficient to achieve therapeutic concentrations in paediatric patients1
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-191
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease1
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population1
Public consultation for European health data space is open1
Spread awareness, stop resistance – getting ready for WAAW and EAAD1
Thoughts on the shortage of vinflunine: could we have done more?1
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU1
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies1
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin1
BCWA: don’t we love abbreviations and acronyms!1
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards1
Development and Delphi validation of a Best Possible Medication History form1
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use1
Off-label use of cardiovascular drugs as an indicator of therapeutic need in paediatrics1
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study0
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions0
Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit0
5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement0
It’s congress time: virtually!0
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements0
To maximise impact, hospital pharmacists need to increase visibility0
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis0
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison0
RETRACTED: Specific features of rational pharmacotherapy in elderly patients0
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study0
Ceftaroline combination therapy for methicillin resistant coagulase negativeStaphylococcusbacteraemia and endocarditis0
Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital0
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs0
Risk of exposure of patients’ family members to lenalidomide at home0
Tocilizumab in COVID-19 management: addressing time of starting treatment0
Feasibility study of the digital tool Max for the patient-provided medication list in the medication reconciliation process prior to hospitalisation: patient willingness and usability, time saved and 0
Development and evaluation of a blended learning training programme for pharmacy technicians’ continuing education0
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients0
Association of polypharmacy with cognitive impairment in older trauma patients: a cross-sectional study0
Implementing an innovative, patient-centered approach to day case arthroplasty: improving patient outcomes through remote preoperative pharmacist consultations0
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients0
0.11959505081177